Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer

by Quisette P. Janssen, Eileen M. O'Reilly, Eileen M. O'Reilly, Casper H. J. van Eijck, Bas Groot Koerkamp
Published 2020-01-01

Circulating mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

by Fleur van der Sijde, Zakia Azmani, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Wilfred F. J. van IJcken, Quisette P. Janssen, Martijn P. Lolkema, Saskia A. C. Luelmo, Leonie J. M. Mekenkamp, Dana A. M. Mustafa, Ron H. N. van Schaik, Johanna W. Wilmink, Eveline E. Vietsch, Casper H. J. van Eijck
Published 2021-08-01